|
|
|
Insider
Information: |
Link Max |
Relationship: |
Director |
City: |
8044 Zurich Switzerland |
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
1,228,236 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$12,462,040 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,228,236 |
|
|
Total
Value |
$12,462,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Juniper Pharmaceuticals Inc |
JNP |
Director |
2003-08-08 |
23,000 |
2003-08-08 |
0 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
Director |
2005-09-30 |
73,572 |
2003-09-25 |
0 |
Premium* |
|
Windtree Therapeutics Inc |
WINT |
Director |
2007-03-09 |
166,821 |
2003-09-25 |
0 |
Premium* |
|
PDL Biopharma Inc |
PDLI |
Director |
2005-11-02 |
159,916 |
2003-09-25 |
0 |
Premium* |
|
Celsion Corp |
CLSN |
Director |
2012-12-10 |
380,385 |
2003-12-22 |
0 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2014-02-28 |
59,469 |
2004-04-06 |
0 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Director |
2008-04-11 |
27,699 |
2007-07-10 |
0 |
Premium* |
|
Ladrx |
LADX |
Director |
2012-02-23 |
260,305 |
2007-04-27 |
0 |
Premium* |
|
Sintx Technologies Ord Shs |
SINT |
Director |
2014-08-12 |
77,069 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SINT |
Sintx Technologies Ord Sh... |
Director |
|
2014-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,984 |
77,069 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
59,469 |
0 |
- |
|
SINT |
Sintx Technologies Ord Sh... |
Director |
|
2014-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
57,864 |
70,666 |
0 |
- |
|
SINT |
Sintx Technologies Ord Sh... |
Director |
|
2014-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,802 |
|
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2014-02-03 |
4 |
S |
$154.02 |
$6,206,219 |
D/D |
(40,000) |
58,574 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,471 |
98,574 |
0 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2012-12-10 |
4 |
B |
$7.60 |
$106,400 |
D/D |
14,000 |
380,385 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2012-09-20 |
4 |
OE |
$2.72 |
$95,200 |
D/D |
35,000 |
296,025 |
0 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2012-09-20 |
4 |
OE |
$2.77 |
$230,263 |
D/D |
70,360 |
366,385 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2012-08-24 |
4 |
OE |
$10.84 |
$1,154,000 |
D/D |
80,000 |
169,781 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2012-08-14 |
4 |
S |
$103.76 |
$10,355,245 |
D/D |
(99,673) |
89,781 |
0 |
- |
|
LADX |
Ladrx |
Director |
|
2012-02-23 |
4 |
B |
$0.33 |
$44,580 |
D/D |
136,540 |
260,305 |
2.39 |
- |
|
LADX |
Ladrx |
Director |
|
2012-02-22 |
4 |
B |
$0.31 |
$21,276 |
D/D |
68,789 |
123,765 |
2.39 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2012-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,115 |
96,103 |
0 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2011-08-09 |
4 |
OE |
$2.40 |
$40,999 |
D/D |
17,083 |
261,025 |
0 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2011-07-25 |
4 |
B |
$4.27 |
$199,998 |
D/D |
46,838 |
243,942 |
2.39 |
- |
|
CLSN |
Celsion Corp |
Director |
|
2011-05-26 |
4 |
B |
$2.77 |
$95,681 |
D/D |
34,542 |
197,104 |
2.39 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2011-02-28 |
4 |
S |
$95.00 |
$4,525,515 |
D/D |
(47,637) |
92,988 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2011-02-22 |
4/A |
A |
$0.00 |
$0 |
D/D |
0 |
140,265 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2011-02-22 |
4 |
S |
$95.00 |
$4,499,865 |
D/D |
(47,367) |
92,898 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2011-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,725 |
140,265 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2010-05-18 |
4 |
OE |
$40.25 |
$603,750 |
D/D |
15,000 |
137,540 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2010-02-18 |
4 |
S |
$49.34 |
$1,973,600 |
D/D |
(40,000) |
122,540 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2010-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,965 |
162,540 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2010-01-19 |
4 |
OE |
$42.06 |
$168,240 |
D/D |
4,000 |
158,575 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|